Maravai Lifesciences PE ratio MRVI

Share price divided by earnings per share over the last twelve months, since 2022.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 167×; Feb 2024
Peer median: 14.1×

Maravai Lifesciences has no meaningful PE ratio today: it lost $0.53 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Feb 2024, at 167×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2024	167×	105×	167×
2023	131×	8.3×	132×
2022	9.0×	8.4×	30.3×

Against its peers

Companies in Drug Manufacturers - General nearest Maravai Lifesciences' size, closest first, today.

Company	PE ratio
MRVIMaravai Lifesciences	n/m
HRMYHarmony Biosciences	11.7×
ANIPANI Pharmaceuticals	15.4×
PBHPrestige Consumer Healthcare	13.4×
PAHCPhibro Animal Health	15.9×
ANABAnaptysbio	10.7×
PCRXPacira BioSciences	104×
NRIXNurix Therapeutics	11.0×
OMEROmeros	10.9×
AMPHAmphastar Pharmaceuticals	14.8×
OGNOrganon	17.9×
Peer median	14.1×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Maravai Lifesciences

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.